<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: AUGUST 8, 2000
OPTICON MEDICAL, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Delaware 33-17922-C 42-1426742
------------------------------- --------------------- ----------------------
(STATE OR OTHER JURISDICTION OF (COMMISSION FILE NO.) (IRS EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
7001 Post Road
Dublin, Ohio 43016
(614) 336-2000
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER
INCLUDING AREA CODE OF REGISTRANT'S
PRINCIPAL EXECUTIVE OFFICES)
Immune Response, Inc.
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
<PAGE> 2
ITEM 5. OTHER EVENTS.
On July 27, 2000, Immune Response, Inc., a Colorado corporation, was
merged with and into its wholly-owned subsidiary, Opticon Medical, Inc., a
Delaware corporation, pursuant to an Agreement and Plan of Merger, dated June
26, 2000, between Immune and Opticon. All outstanding shares of Immune stock
were automatically converted into the same number of shares of Opticon stock.
Immune's press release, issued July 28, 2000, regarding the merger of
Immune into Opticon, is attached as an exhibit to this report and is
incorporated in this Form 8-K by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS.
EXHIBIT NO. DESCRIPTION
99.1 Immune Response, Inc.'s Press Release,
issued July 28, 2000, regarding the merger
of Immune into Opticon Medical, Inc.
99.2 Agreement and Plan of Merger, dated June 26,
2000, between Immune Response, Inc. and
Opticon Medical, Inc.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
OPTICON MEDICAL, INC.
Date: August 8, 2000 By: /s/ William J. Post
--------------------------------
William J. Post, President and
Chief Executive Officer
3
<PAGE> 4
EXHIBIT INDEX
-------------
EXHIBIT NO. DESCRIPTION
99.1* Immune Response, Inc.'s Press Release, issued July 28, 2000,
regarding the merger of Immune into Opticon Medical, Inc.
99.2* Agreement and Plan of Merger, dated June 26, 2000, between
Immune Response, Inc. and Opticon Medical, Inc.
--------------------------------
* Filed with this report.
